Trinity Biotech 

$9.60
18
+$0.00+0% Thursday 20:00
-$0.07-0.73%Thursday 20:00After hours

Statistics

Day High
9.65
Day Low
9.65
52W High
52.5
52W Low
7.94
Volume
1
Avg. Volume
-
Mkt Cap
7.81M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 15
$6.60
Jul 14
$6.60
Jul 13
$6.00
Jun 12
$4.50
Jun 11
$3.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7MayExpected
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q3 2023
Q4 2023
Q1 2024
-0.29
-0.17
-0.05
0.07
Expected EPS
-0.12
Actual EPS
0

Financials

-85.36%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
43.79MRevenue
-37.38MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TRIB. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers a range of products for the clinical diagnostics market, directly competing with Trinity Biotech's diagnostic products.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a broad array of medical devices, diagnostics, and nutritional products, competing in the diagnostics segment.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of diagnostics and research products, overlapping with Trinity Biotech's offerings.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing, information, and services, competing in the clinical laboratory services market.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America offers clinical laboratory tests and services, directly competing with Trinity Biotech's diagnostic services.
QuidelOrtho
QDEL
Mkt Cap1.01B
Quidel Corporation specializes in diagnostic healthcare products, including rapid diagnostic testing solutions, competing in the same market as Trinity Biotech.
Baxter International
BAX
Mkt Cap13.51B
Baxter International develops, manufactures, and markets products that save and sustain the lives of people, including diagnostic products.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company offers a variety of medical devices and diagnostic products, competing in the healthcare and diagnostics sectors.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates businesses in the diagnostics, life sciences, and environmental and applied solutions sectors, competing across several of Trinity Biotech's product lines.

About

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Show more...
CEO
John Gillard
Employees
287
Country
Ireland
ISIN
US8964386036
WKN
000A41G7H

Listings

0 Comments

Share your thoughts

FAQ

What is Trinity Biotech stock price today?
The current price of TRIB is $9.60 USD — it has increased by +0% in the past 24 hours. Watch Trinity Biotech stock price performance more closely on the chart.
What is Trinity Biotech stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Trinity Biotech stocks are traded under the ticker TRIB.
Is Trinity Biotech stock price growing?
TRIB stock has fallen by -1.54% compared to the previous week, the month change is a -12.73% fall, over the last year Trinity Biotech has showed a +734.78% increase.
What is Trinity Biotech market cap?
Today Trinity Biotech has the market capitalization of 7.81M
What were Trinity Biotech earnings last quarter?
TRIB earnings for the last quarter are 0 USD per share, whereas the estimation was -0.12 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Trinity Biotech revenue for the last year?
Trinity Biotech revenue for the last year amounts to 43.79M USD.
What is Trinity Biotech net income for the last year?
TRIB net income for the last year is -37.38M USD.
Does Trinity Biotech pay dividends?
Yes, TRIB dividends are paid annual. The last dividend per share was 6.6 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Trinity Biotech have?
As of September 04, 2026, the company has 287 employees.
In which sector is Trinity Biotech located?
Trinity Biotech operates in the Health & Wellness sector.
When did Trinity Biotech complete a stock split?
The last stock split for Trinity Biotech was on July 24, 2026 with a ratio of 1:30.
Where is Trinity Biotech headquartered?
Trinity Biotech is headquartered in Bray, Ireland.